ENTITY
Hutchison China MediTech Ltd

Hutchison China MediTech Ltd (HCM US)

45
Analysis
Health Care • Hong Kong
Hutchison China MediTech Ltd develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech markets its products globally.
more
bullish•Coupang
•14 Mar 2021 10:15

ECM Weekly (14th March 2021) - Coupang, Baidu, Shanghai Heartcare, Chaoju Eye Care, Linklogis, Tuya

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullish•InnoCare Pharma Ltd
•10 Feb 2021 09:34

InnoCare Pharma Ltd (9969.HK) - What Attracts Both Hillhouse and Vivo Capital?

The article analyzed whatĀ InnoCare attracts both Hillhouse and Vivo Capital in terms of its core product orelabrutinib, other products (ICP-192/ICP...

Logo
417 Views
Share
bullish•BeiGene
•10 Jan 2021 05:35

BeiGene: Cancer Treatment in China--The Underestimated Opportunity

We think that cancer is underdiagnosed and undertreated in China. We analyze the data and propose two approaches for investing in this theme.

Share
•03 Jan 2021 09:27

China Healthcare Weekly (Dec.31)

This article summarized the industry viewpoints including theĀ results of China 2020 medical insurance negotiations, TDDS, companies news of...

Logo
447 Views
Share
•26 Jan 2020 11:42

ECM Weekly (26 Jan 2020) - Central Retail Corp, Smoore, Mindspace Biz Parks REIT, Elite Comm REIT

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Happy...

Share
x